ESR1 and prostate carcinoma: This study also highlights a unique property of carnosol wherein it functions as a dual disruptor of both androgen receptor (AR) and estrogen receptor α (ERα) in vitro in prostate cancer cells (LNCaP and 22Rv1) as well as in vivo in nude mice (Johnson et al., 2010).